Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From DiaSorin SpA
German reimbursement of COVID-19 confirmatory tests has been reduced by one third, a decision that has frustrated both the testing labs and the diagnostics manufacturers who jointly provided the basis of the system that kept the coronavirus to within manageable proportions nationally.
The US government is helping Sonica develop ADAM, a patch monitor that tracks the user's breathing patterns and other physiologic signals to detect SARS-CoV-2 infections.
The company says the serology test has a specificity of 99.8% and sensitivity of 100%
Italy must ensure that ongoing efforts to tackle the coronavirus crisis do not rely on single suppliers, the country's medtech industry body said after DiaSorin looked likely to be the sole winner of a major COVID-19 diagnostics tender.
- Diagnostic Equipment & Supplies
In Vitro Diagnostics
- Chemistry, Immunoassay
- Other Names / Subsidiaries
- Biotrin International
- DiaSorin Molecuular
- Focus Diagnostics